Based on the knowledge of electroconvulsive treatment, the nurse explains to the student nurses that atropine is given before the treatment primarily to:

Appeared in: AIIMS Nagpur NO- 2020

Explanation

Atropine is an anticholinergic medication given as a premedication before ECT.
Its primary function is to decrease or minimize oral and respiratory secretions.
This effect is crucial because ECT involves a temporary loss of consciousness and protective airway reflexes during an induced seizure.
By drying secretions, atropine significantly reduces the risk of the patient inhaling saliva or mucus into their lungs (aspiration), which could lead to serious complications like pneumonia.

Why Other Options Were Wrong

Option A: This is the opposite of atropine's intended effect. As an anticholinergic agent, atropine blocks muscarinic receptors, leading to a reduction in secretions.
Option B: While atropine does have an antispasmodic effect on the smooth muscle of the intestines, this is considered a secondary effect in the context of ECT and not the main reason for its administration.
Option C: Atropine does not have properties to reduce anxiety. Anxiolytic medications, such as benzodiazepines (e.g., lorazepam), are used for this purpose.

Related Visual

Clinical Relevance

Nursing practice connection: Safe nursing care depends on performing Pharmacological Premedication for Electroconvulsive Therapy (ECT) in the correct sequence, documenting the action clearly, and monitoring for the expected response.
Nurses play a vital role in the safe administration of ECT, which includes ensuring premedications are given correctly, verifying NPO status, and monitoring for effects and side effects like dry mouth and tachycardia.
Post-procedure, the nurse is responsible for monitoring vital signs, assessing for confusion or headache, reorienting the patient, and providing emotional support.
What if? If a patient has narrow-angle glaucoma or significant pre-existing tachycardia, atropine may be contraindicated. In such cases, glycopyrrolate is often the preferred anticholinergic as it does not readily cross the blood-brain barrier and has different cardiovascular effects.

How to Approach the Question

First, identify the key components of the question: the drug (atropine), the procedure (ECT), and the question's focus ('primarily to').
Recall the pharmacological class of atropine, which is an anticholinergic drug.
Remember the primary effects of anticholinergics, often summarized by the mnemonic: 'can't see, can't pee, can't spit, can't shit.' The 'can't spit' part refers to drying up secretions.
Consider the risks associated with ECT. The procedure involves anesthesia and an induced seizure, which means the patient loses their protective airway reflexes.
Connect the drug's action to the procedure's risk. Drying secretions (atropine's effect) directly addresses the risk of inhaling those secretions (aspiration) when the airway is unprotected.
Evaluate each option based on this connection. Preventing aspiration is the most direct and critical safety reason for reducing secretions in this context.

Concept Tested & Keywords

Concept Tested: Pharmacological Premedication for Electroconvulsive Therapy (ECT)
Stem keywords: electroconvulsive treatment, ECT, atropine, before treatment
Lead-in keywords: primarily to
Negative lead-in flag: false

Question ID

QEBT1uz1zMOrnr4sg1tMaW

Reference Book

E6 Kaplan Sadock's Synopsis of Psychiatry-2022 (pp 1-3768 of 3768) pp. 2303-2305, 2302-2304

E6 Robert Boland, Marcia L. Verduin - Kaplan and Sadock's Comprehensive Text of Psychiatry-Wolters Kluwer Health (2024) (pp 1-16525 of 16525) p. 11191-11193

Practise the full AIIMS Nagpur NO- 2020

Attempt every question from this paper in a timed mock, then review the full solution for each one.

Attempt this paper Attempt in the NPrep app